A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma.Emily K. Slotkin,Audrey Mauguen,Michael Vincent Ortiz,Filemon S. Dela Cruz, Tara O'Donohue,Michael David Kinnaman,Paul A. Meyers,Leonard H. Wexler, Scarlett Rodriguez,Viswatej Avutu,Ciara Marie Kelly,Sandra P. D'Angelo,Mary Louise Keohan,Mrinal M. Gounder,Benjamin Alexander Nacev,Evan Rosenbaum,Mark Andrew Dickson,Katherine Anne Thornton,Julia Lynne Glade Bender,William D. TapJOURNAL OF CLINICAL ONCOLOGY（2022）引用 4|浏览16暂无评分关键词rhabdomyosarcoma,tumor,prexasertib,irinotecanAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
